Formulated composition
US7186686B2 · kind B2 · utility
0Cited by
15References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2003 |
| Grant date | Mar 6, 2007 |
| Priority date | — |
| Expiry date | Oct 26, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/808
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition is disclosed that comprises a mixture of polypeptides of opposite charge and an excipient selected from the group consisting of arginine, lysine, glutamic acid, sodium dodecyl sulfate, beta-hydroxy cyclodextrin, and beta-cyclodextrin sulfobutyl ether.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.